Advertisement

Loading...

Ceres Ventures, Inc.

CEVEPNK
Healthcare
Medical - Care Facilities
$0.00
$0.00(0.00%)
U.S. Market is Open • 11:44

Ceres Ventures, Inc. Fundamental Analysis

Ceres Ventures, Inc. (CEVE) shows weak financial fundamentals with a PE ratio of -0.02, profit margin of 0.00%, and ROE of 2.26%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position832.09%
PEG Ratio-0.00

Areas of Concern

ROE2.26%
Operating Margin0.00%
Current Ratio0.21
We analyze CEVE's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 54.8/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
54.8/100

We analyze CEVE's fundamental strength across five key dimensions:

Efficiency Score

Weak

CEVE struggles to generate sufficient returns from assets.

ROA > 10%
-3.47%

Valuation Score

Excellent

CEVE trades at attractive valuation levels.

PE < 25
-0.02
PEG Ratio < 2
-0.00

Growth Score

Weak

CEVE faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

CEVE shows balanced financial health with some risks.

Debt/Equity < 1
-0.28
Current Ratio > 1
0.21

Profitability Score

Weak

CEVE struggles to sustain strong margins.

ROE > 15%
225.93%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is CEVE Expensive or Cheap?

P/E Ratio

CEVE trades at -0.02 times earnings. This suggests potential undervaluation.

-0.02

PEG Ratio

When adjusting for growth, CEVE's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Ceres Ventures, Inc. at -0.03 times its book value. This may indicate undervaluation.

-0.03

EV/EBITDA

Enterprise value stands at -0.03 times EBITDA. This is generally considered low.

-0.03

How Well Does CEVE Make Money?

Net Profit Margin

For every $100 in sales, Ceres Ventures, Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $2.26 in profit for every $100 of shareholder equity.

2.26%

ROA

Ceres Ventures, Inc. generates $-3.47 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.47%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.00 in free cash annually.

$-0.00

FCF Yield

CEVE converts -15.18% of its market value into free cash.

-15.18%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.02

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.03

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.28

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.21

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

2.26

vs 25 benchmark

ROA

Return on assets percentage

-3.47

vs 25 benchmark

ROCE

Return on capital employed

1.50

vs 25 benchmark

How CEVE Stacks Against Its Sector Peers

MetricCEVE ValueSector AveragePerformance
P/E Ratio-0.0227.91 Better (Cheaper)
ROE225.93%687.00% Weak
Net Margin0.00%-45285.00% (disorted) Weak
Debt/Equity-0.280.33 Strong (Low Leverage)
Current Ratio0.212795.76 Weak Liquidity
ROA-346.69%-13557.00% (disorted) Weak

CEVE outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Ceres Ventures, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ